Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -285,305 | -172,135 | -120,683 | -32,875 | -130,778 |
| Depreciation Amortization | 5,921 | 4,166 | 2,646 | 1,265 | 1,826 |
| Accounts payable and accrued liabilities | 1,982 | 2,414 | 1,864 | 2,370 | N/A |
| Other Working Capital | 6,156 | 3,492 | -1,850 | -1,113 | 10,526 |
| Other Operating Activity | 133,264 | 61,640 | 55,110 | 806 | 32,922 |
| Operating Cash Flow | $-137,982 | $-100,423 | $-62,913 | $-29,547 | $-85,504 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,872 | -14,606 | -8,290 | -5,600 | -26,124 |
| Net Acquisitions | 0 | N/A | N/A | N/A | -3,195 |
| Purchase Of Investment | -387,432 | -307,398 | -43,121 | 0 | N/A |
| Sale Of Investment | 158,741 | 56,400 | 54,120 | 44,781 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -58,542 |
| Investing Cash Flow | $-252,563 | $-265,604 | $2,709 | $39,181 | $-87,861 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 149 | 46 | 37 | N/A | N/A |
| Other Financing Activity | 435,538 | 435,538 | 435,543 | 2 | 223,726 |
| Financing Cash Flow | $435,687 | $435,584 | $435,580 | $2 | $223,726 |
| Beginning Cash Position | 81,807 | 81,807 | 81,807 | 81,807 | 31,446 |
| End Cash Position | 126,949 | 151,364 | 457,183 | 91,443 | 81,807 |
| Net Cash Flow | $45,142 | $69,557 | $375,376 | $9,636 | $50,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137,982 | -100,423 | -62,913 | -29,547 | -85,504 |
| Capital Expenditure | -23,872 | -14,606 | -8,290 | -5,600 | N/A |
| Free Cash Flow | -161,854 | -115,029 | -71,203 | -35,147 | -85,504 |